EFFICACY OF GUDADIGUTIKA AND SAMSHARKARA CHURNA IN MANAGING KAPHAJA KASA: A CONTROLLED CLINICAL STUDY

Introduction: Kaphaja Kasa (cough due to excess Kapha) is a common respiratory ailment in Ayurveda, presenting significant discomfort and potential complications if untreated. The aim of this study was to assess the efficacy of two Ayurvedic formulations, Gudadigutika and Samsharkara Churna, in managing Kaphaja Kasa through a controlled clinical trial. Methods: A randomized controlled clinical study was conducted with 40 patients diagnosed with Kaphaja Kasa. The patients were divided into two groups: Group A received Gudadigutika (500 mg, thrice daily), and Group B received Samsharkara Churna (15 g/day, divided into three doses). Both treatments were administered for 14 days with a follow-up on the 21st day. Statistical analysis included paired t-tests for intra-group comparisons and Mann-Whitney U tests for inter-group comparisons. Results: The intra-group analysis revealed that both treatments led to statistically significant improvements in subjective symptoms of Kaphaja Kasa (p < 0.05). However, the comparison between Group A and Group B did not show statistically significant differences (p > 0.05), indicating comparable efficacy of Gudadigutika and Samsharkara Churna. Discussion: Both Gudadigutika and Samsharkara Churna proved effective in managing Kaphaja Kasa. Although no significant difference was observed between the two groups, both formulations contributed to notable symptomatic relief. Further research with larger sample sizes and long-term follow-ups is needed to explore the broader implications of these findings in Ayurvedic respiratory care.